世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い
 CRISPR-Cas9遺伝子編集サービス-世界市場シェア・ランキング、全体売上高・需要予測 2025-2031CRISPR-Cas9 Gene Editing Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031 CRISPR-Cas9遺伝子編集サービスの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。 CRISPR-Cas9... もっと見る
※当ページの内容はウェブ更新時の情報です。 
サマリーCRISPR-Cas9遺伝子編集サービスの世界市場は、2024年には100万米ドル規模になると推定され、2031年には100万米ドルに再調整され、予測期間2025-2031年の年平均成長率は%になると予測されている。CRISPR-Cas9遺伝子編集サービスの北米市場は、2024年に100万米ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万米ドルに達すると予測されています。 CRISPR-Cas9遺伝子編集サービスのアジア太平洋市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中に％のCAGRで、2031年までに100万ドルに達するだろう。 CRISPR-Cas9遺伝子編集サービスのヨーロッパ市場は、2024年に100万ドルと評価され、2025年から2031年の予測期間中にCAGR %で、2031年までに100万ドルに達するでしょう。 CRISPR-Cas9遺伝子編集サービスの世界の主要企業には、AMSBIO、GenScript、Merck、Editas Medicine、Intellia Therapeutics、CRISPR Therapeutics、DefiniGEN、Synthego、Biocytogen、Caribouなどが含まれる。2024年には、世界の大手5社が売上高で約 %のシェアを占めている。 本レポートは、CRISPR-Cas9遺伝子編集サービスの世界市場を包括的に紹介することを目的としており、CRISPR-Cas9遺伝子編集サービスの地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 CRISPR-Cas9 遺伝子編集サービスの市場規模、推計、予測は、2024年を基準年として、2020年から2031年までの期間の履歴データと予測データを売上高（百万ドル）で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、CRISPR-Cas9遺伝子編集サービスに関する情報に基づいたビジネス上の意思決定を行うことを支援します。 市場区分 企業別 AMSBIO ジェンスクリプト メルク エディタス インテリア・セラピューティクス CRISPRセラピューティクス デフィニジェン シンセゴ バイオシトゲン カリブー ホライゾン・ディスカバリー社 エディジーン社 デタイバイオ タイプ別セグメント ノックイン遺伝子編集サービス ノックアウト遺伝子編集サービス その他 アプリケーション別 細胞株構築 動物モデル バイオ農業 その他 地域別 北米 アメリカ カナダ アジア太平洋 中国 日本 韓国 東南アジア インド オーストラリア その他のアジア太平洋地域 ヨーロッパ ドイツ フランス 英国 イタリア オランダ 北欧諸国 その他のヨーロッパ ラテンアメリカ メキシコ ブラジル その他のラテンアメリカ 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 その他のMEA 各章の概要 第1章： レポートのスコープ、世界の総市場規模を紹介します。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章：CRISPR-Cas9遺伝子編集サービス企業の競争環境、収益市場シェア、最新の開発計画、M&A情報などを詳細に分析。 第3章：タイプ別に様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけることを支援する。 第4章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章：地域レベルでのCRISPR-Cas9遺伝子編集サービスの収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来発展展望、市場空間、市場規模を紹介しています。 第6章 CRISPR-Cas9遺伝子編集サービスの国別売上高各国/地域のタイプ別、用途別のシグメイトデータを提供。 第7章：主要企業のプロフィールを提供し、製品収益、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章：産業の上流と下流を含む産業チェーンの分析。 第9章：結論 目次1 Market Overview1.1 CRISPR-Cas9 Gene Editing Service Product Introduction 1.2 Global CRISPR-Cas9 Gene Editing Service Market Size Forecast (2020-2031) 1.3 CRISPR-Cas9 Gene Editing Service Market Trends & Drivers 1.3.1 CRISPR-Cas9 Gene Editing Service Industry Trends 1.3.2 CRISPR-Cas9 Gene Editing Service Market Drivers & Opportunity 1.3.3 CRISPR-Cas9 Gene Editing Service Market Challenges 1.3.4 CRISPR-Cas9 Gene Editing Service Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global CRISPR-Cas9 Gene Editing Service Players Revenue Ranking (2024) 2.2 Global CRISPR-Cas9 Gene Editing Service Revenue by Company (2020-2025) 2.3 Key Companies CRISPR-Cas9 Gene Editing Service Manufacturing Base Distribution and Headquarters 2.4 Key Companies CRISPR-Cas9 Gene Editing Service Product Offered 2.5 Key Companies Time to Begin Mass Production of CRISPR-Cas9 Gene Editing Service 2.6 CRISPR-Cas9 Gene Editing Service Market Competitive Analysis 2.6.1 CRISPR-Cas9 Gene Editing Service Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by CRISPR-Cas9 Gene Editing Service Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Cas9 Gene Editing Service as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Knock-in Gene Editing Service 3.1.2 Knock-out Gene Editing Service 3.1.3 Other 3.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type 3.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Type (2020-2031) 3.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Cell Line Construction 4.1.2 Animal Models 4.1.3 Bioagriculture 4.1.4 Other 4.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application 4.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Application (2020-2031) 4.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region 5.1.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2020-2025) 5.1.3 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2026-2031) 5.1.4 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.2.2 North America CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.3.2 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.4.2 Asia Pacific CRISPR-Cas9 Gene Editing Service Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.5.2 South America CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.6.2 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions CRISPR-Cas9 Gene Editing Service Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.3 United States 6.3.1 United States CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.3.2 United States CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.3.3 United States CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.4.2 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.5.2 China CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.5.3 China CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.6.2 Japan CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.7.2 South Korea CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.8.2 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.9.2 India CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.9.3 India CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 AMSBIO 7.1.1 AMSBIO Profile 7.1.2 AMSBIO Main Business 7.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.1.5 AMSBIO Recent Developments 7.2 GenScript 7.2.1 GenScript Profile 7.2.2 GenScript Main Business 7.2.3 GenScript CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.2.4 GenScript CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.2.5 GenScript Recent Developments 7.3 Merck 7.3.1 Merck Profile 7.3.2 Merck Main Business 7.3.3 Merck CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.3.4 Merck CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.3.5 Merck Recent Developments 7.4 Editas Medicine 7.4.1 Editas Medicine Profile 7.4.2 Editas Medicine Main Business 7.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.4.5 Editas Medicine Recent Developments 7.5 Intellia Therapeutics 7.5.1 Intellia Therapeutics Profile 7.5.2 Intellia Therapeutics Main Business 7.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.5.5 Intellia Therapeutics Recent Developments 7.6 CRISPR Therapeutics 7.6.1 CRISPR Therapeutics Profile 7.6.2 CRISPR Therapeutics Main Business 7.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.6.5 CRISPR Therapeutics Recent Developments 7.7 DefiniGEN 7.7.1 DefiniGEN Profile 7.7.2 DefiniGEN Main Business 7.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.7.5 DefiniGEN Recent Developments 7.8 Synthego 7.8.1 Synthego Profile 7.8.2 Synthego Main Business 7.8.3 Synthego CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.8.4 Synthego CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.8.5 Synthego Recent Developments 7.9 Biocytogen 7.9.1 Biocytogen Profile 7.9.2 Biocytogen Main Business 7.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.9.5 Biocytogen Recent Developments 7.10 Caribou 7.10.1 Caribou Profile 7.10.2 Caribou Main Business 7.10.3 Caribou CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.10.4 Caribou CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.10.5 Caribou Recent Developments 7.11 Horizon Discovery Ltd. 7.11.1 Horizon Discovery Ltd. Profile 7.11.2 Horizon Discovery Ltd. Main Business 7.11.3 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.11.5 Horizon Discovery Ltd. Recent Developments 7.12 EdiGene, Inc. 7.12.1 EdiGene, Inc. Profile 7.12.2 EdiGene, Inc. Main Business 7.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.12.5 EdiGene, Inc. Recent Developments 7.13 DetaiBio 7.13.1 DetaiBio Profile 7.13.2 DetaiBio Main Business 7.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.13.5 DetaiBio Recent Developments 8 Industry Chain Analysis 8.1 CRISPR-Cas9 Gene Editing Service Industrial Chain 8.2 CRISPR-Cas9 Gene Editing Service Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 CRISPR-Cas9 Gene Editing Service Sales Model 8.5.2 Sales Channel 8.5.3 CRISPR-Cas9 Gene Editing Service Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for CRISPR-Cas9 Gene Editing Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031. Table of Contents1 Market Overview1.1 CRISPR-Cas9 Gene Editing Service Product Introduction 1.2 Global CRISPR-Cas9 Gene Editing Service Market Size Forecast (2020-2031) 1.3 CRISPR-Cas9 Gene Editing Service Market Trends & Drivers 1.3.1 CRISPR-Cas9 Gene Editing Service Industry Trends 1.3.2 CRISPR-Cas9 Gene Editing Service Market Drivers & Opportunity 1.3.3 CRISPR-Cas9 Gene Editing Service Market Challenges 1.3.4 CRISPR-Cas9 Gene Editing Service Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global CRISPR-Cas9 Gene Editing Service Players Revenue Ranking (2024) 2.2 Global CRISPR-Cas9 Gene Editing Service Revenue by Company (2020-2025) 2.3 Key Companies CRISPR-Cas9 Gene Editing Service Manufacturing Base Distribution and Headquarters 2.4 Key Companies CRISPR-Cas9 Gene Editing Service Product Offered 2.5 Key Companies Time to Begin Mass Production of CRISPR-Cas9 Gene Editing Service 2.6 CRISPR-Cas9 Gene Editing Service Market Competitive Analysis 2.6.1 CRISPR-Cas9 Gene Editing Service Market Concentration Rate (2020-2025) 2.6.2 Global 5 and 10 Largest Companies by CRISPR-Cas9 Gene Editing Service Revenue in 2024 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR-Cas9 Gene Editing Service as of 2024) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Knock-in Gene Editing Service 3.1.2 Knock-out Gene Editing Service 3.1.3 Other 3.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type 3.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Type (2020 VS 2024 VS 2031) 3.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Type (2020-2031) 3.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Type (%) (2020-2031) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Cell Line Construction 4.1.2 Animal Models 4.1.3 Bioagriculture 4.1.4 Other 4.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application 4.2.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Application (2020 VS 2024 VS 2031) 4.2.2 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Application (2020-2031) 4.2.3 Global CRISPR-Cas9 Gene Editing Service Sales Value, by Application (%) (2020-2031) 5 Segmentation by Region 5.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region 5.1.1 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region: 2020 VS 2024 VS 2031 5.1.2 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2020-2025) 5.1.3 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (2026-2031) 5.1.4 Global CRISPR-Cas9 Gene Editing Service Sales Value by Region (%), (2020-2031) 5.2 North America 5.2.1 North America CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.2.2 North America CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.3 Europe 5.3.1 Europe CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.3.2 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.4 Asia Pacific 5.4.1 Asia Pacific CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.4.2 Asia Pacific CRISPR-Cas9 Gene Editing Service Sales Value by Region (%), 2024 VS 2031 5.5 South America 5.5.1 South America CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.5.2 South America CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 5.6 Middle East & Africa 5.6.1 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 5.6.2 Middle East & Africa CRISPR-Cas9 Gene Editing Service Sales Value by Country (%), 2024 VS 2031 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions CRISPR-Cas9 Gene Editing Service Sales Value Growth Trends, 2020 VS 2024 VS 2031 6.2 Key Countries/Regions CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.3 United States 6.3.1 United States CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.3.2 United States CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.3.3 United States CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.4 Europe 6.4.1 Europe CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.4.2 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.4.3 Europe CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.5 China 6.5.1 China CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.5.2 China CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.5.3 China CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.6 Japan 6.6.1 Japan CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.6.2 Japan CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.6.3 Japan CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.7 South Korea 6.7.1 South Korea CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.7.2 South Korea CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.7.3 South Korea CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.8 Southeast Asia 6.8.1 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.8.2 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.8.3 Southeast Asia CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 6.9 India 6.9.1 India CRISPR-Cas9 Gene Editing Service Sales Value, 2020-2031 6.9.2 India CRISPR-Cas9 Gene Editing Service Sales Value by Type (%), 2024 VS 2031 6.9.3 India CRISPR-Cas9 Gene Editing Service Sales Value by Application, 2024 VS 2031 7 Company Profiles 7.1 AMSBIO 7.1.1 AMSBIO Profile 7.1.2 AMSBIO Main Business 7.1.3 AMSBIO CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.1.4 AMSBIO CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.1.5 AMSBIO Recent Developments 7.2 GenScript 7.2.1 GenScript Profile 7.2.2 GenScript Main Business 7.2.3 GenScript CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.2.4 GenScript CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.2.5 GenScript Recent Developments 7.3 Merck 7.3.1 Merck Profile 7.3.2 Merck Main Business 7.3.3 Merck CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.3.4 Merck CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.3.5 Merck Recent Developments 7.4 Editas Medicine 7.4.1 Editas Medicine Profile 7.4.2 Editas Medicine Main Business 7.4.3 Editas Medicine CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.4.4 Editas Medicine CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.4.5 Editas Medicine Recent Developments 7.5 Intellia Therapeutics 7.5.1 Intellia Therapeutics Profile 7.5.2 Intellia Therapeutics Main Business 7.5.3 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.5.4 Intellia Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.5.5 Intellia Therapeutics Recent Developments 7.6 CRISPR Therapeutics 7.6.1 CRISPR Therapeutics Profile 7.6.2 CRISPR Therapeutics Main Business 7.6.3 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.6.4 CRISPR Therapeutics CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.6.5 CRISPR Therapeutics Recent Developments 7.7 DefiniGEN 7.7.1 DefiniGEN Profile 7.7.2 DefiniGEN Main Business 7.7.3 DefiniGEN CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.7.4 DefiniGEN CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.7.5 DefiniGEN Recent Developments 7.8 Synthego 7.8.1 Synthego Profile 7.8.2 Synthego Main Business 7.8.3 Synthego CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.8.4 Synthego CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.8.5 Synthego Recent Developments 7.9 Biocytogen 7.9.1 Biocytogen Profile 7.9.2 Biocytogen Main Business 7.9.3 Biocytogen CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.9.4 Biocytogen CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.9.5 Biocytogen Recent Developments 7.10 Caribou 7.10.1 Caribou Profile 7.10.2 Caribou Main Business 7.10.3 Caribou CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.10.4 Caribou CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.10.5 Caribou Recent Developments 7.11 Horizon Discovery Ltd. 7.11.1 Horizon Discovery Ltd. Profile 7.11.2 Horizon Discovery Ltd. Main Business 7.11.3 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.11.4 Horizon Discovery Ltd. CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.11.5 Horizon Discovery Ltd. Recent Developments 7.12 EdiGene, Inc. 7.12.1 EdiGene, Inc. Profile 7.12.2 EdiGene, Inc. Main Business 7.12.3 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.12.4 EdiGene, Inc. CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.12.5 EdiGene, Inc. Recent Developments 7.13 DetaiBio 7.13.1 DetaiBio Profile 7.13.2 DetaiBio Main Business 7.13.3 DetaiBio CRISPR-Cas9 Gene Editing Service Products, Services and Solutions 7.13.4 DetaiBio CRISPR-Cas9 Gene Editing Service Revenue (US$ Million) & (2020-2025) 7.13.5 DetaiBio Recent Developments 8 Industry Chain Analysis 8.1 CRISPR-Cas9 Gene Editing Service Industrial Chain 8.2 CRISPR-Cas9 Gene Editing Service Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 CRISPR-Cas9 Gene Editing Service Sales Model 8.5.2 Sales Channel 8.5.3 CRISPR-Cas9 Gene Editing Service Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.1.1 Research Programs/Design 10.1.1.2 Market Size Estimation 10.1.1.3 Market Breakdown and Data Triangulation 10.1.2 Data Source 10.1.2.1 Secondary Sources 10.1.2.2 Primary Sources 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（ソフトウェア）の最新刊レポート
QYResearch社のサービス・ソフトウェア分野での最新刊レポート
本レポートと同じKEY WORD（gene）の最新刊レポートよくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2025/05/21 10:26 145.28 円 164.45 円 197.45 円 |
